United States Biotechnology & Medical Research

Oramed Pharmaceuticals Inc (ORMP)

Track

Over the past 90 days, Oramed Pharmaceuticals Inc. insiders executed four transactions totaling approximately $2.05 million in sales. These activities involved the COO, CBO, and CFO, primarily through planned and proposed sales on July 1, 2026. These transactions occurred following the company's June 2026 results financiers.
Ticker: ORMP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Oramed Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 1 Jul 2026
Value US$268,443.00 | Price 236.44 | Shares 46,541 (-20.5%)
Proposed sale 1 Jul 2026
Value US$2,253,141.21 | Price 248.75 | Shares 8,155
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-02 2026-07-01 PlS Planned sale
Gabay Avraham

Chief Financial Officer

Officer
46,541 -20.5%
236.44
US$268,443 		46,541 -20.5% 236.44 US$268,443
2026-07-02 2026-07-01 PlS Planned sale
Hexter Joshua

COO & CBO

Officer
2,600 +30.2%
55.30
US$368,968 		2,600 +30.2% 55.30 US$368,968
2026-07-01 2026-07-01 PrS Proposed sale
Hexter Joshua

Officer

Officer
31,488
172.07
US$4,178,165 		31,488 172.07 US$4,178,165
2026-07-01 2026-07-01 PrS Proposed sale
Gabay Avraham

Officer

Officer
93,360
4.81
US$449,062 		93,360 4.81 US$449,062
2023-04-04 2023-04-04 B Purchase
4.0
Mayer Arie
Non-Executive Director
3,800 +16.5%
2.21
US$8,398 		3,800 +16.5% 2.21 US$8,398
2023-04-04 2023-04-03 B Purchase
4.0
Mayer Arie
Non-Executive Director
5,009 +27.8%
2.22
US$11,120 		5,009 +27.8% 2.22 US$11,120
2023-03-16 2023-03-16 B Purchase
3.6
KIDRON NADAV

President and CEO

Executive Director
26,000 +26.0%
2.04
US$53,014 		26,000 +26.0% 2.04 US$53,014
2023-03-15 2023-03-14 S Sale
0.5
Kidron Miriam

Chief Scientific Officer

Executive Director
100,000 -33.1%
2.01
US$201,000 		100,000 -33.1% 2.01 US$201,000
2023-03-15 2023-03-14 B Purchase
3.6
KIDRON NADAV

President and CEO

Executive Director
100,000 +inf%
2.01
US$201,000 		100,000 +inf% 2.01 US$201,000
2023-03-15 2023-03-14 B Purchase
4.1
Rozov Yadin
Non-Executive Director
50,000 +137.0%
2.05
US$102,450 		50,000 +137.0% 2.05 US$102,450
2023-03-15 2023-03-13 B Purchase
4.1
Rozov Yadin
Non-Executive Director
20,000 +121.2%
1.96
US$39,120 		20,000 +121.2% 1.96 US$39,120
2023-01-04 2023-01-03 PlS Planned sale
Rabinowitz Michael

Chief Commercial Officer

Officer
11,900 -8.6%
12.49
US$148,651 		11,900 -8.6% 12.49 US$148,651
2023-01-04 2023-01-03 PlS Planned sale
Rabinowitz Michael

Chief Commercial Officer

Officer
1,425 -1.0%
13.01
US$18,544 		1,425 -1.0% 13.01 US$18,544
2022-03-22 2022-03-21 S Sale
3.5
RAKIN KEVIN
Non-Executive Director
10,000 -17.6%
9.41
US$94,096 		10,000 -17.6% 9.41 US$94,096
2022-05-10 2021-11-01 S Sale
4.0
Mayer Arie
Non-Executive Director
3,000 -100.0%
25.60
US$76,800 		3,000 -100.0% 25.60 US$76,800
2021-08-11 2021-08-09 PlS Planned sale
3.6
KIDRON NADAV

President and CEO

Executive Director Large shareholder
220,000 -25.3%
20.11
US$4,423,144 		220,000 -25.3% 20.11 US$4,423,144
2019-09-11 2019-09-09 B Purchase
2.2
Sank Leonard
10,000 +2.7%
2.95
US$29,500 		10,000 +2.7% 2.95 US$29,500
2019-09-11 2019-09-09 B Purchase
2.2
Sank Leonard
15,000 +4.3%
2.90
US$43,500 		15,000 +4.3% 2.90 US$43,500
2019-07-18 2019-07-18 B Purchase
2.2
Sank Leonard
4,497 +1.3%
3.86
US$17,336 		4,497 +1.3% 3.86 US$17,336
2019-07-18 2019-07-17 B Purchase
2.2
Sank Leonard
10,020 +3.0%
3.74
US$37,497 		10,020 +3.0% 3.74 US$37,497
2019-07-18 2019-07-17 B Purchase
2.2
Sank Leonard
20,000 +6.3%
3.58
US$71,562 		20,000 +6.3% 3.58 US$71,562
2019-07-18 2019-07-16 B Purchase
2.2
Sank Leonard
20,000 +6.8%
3.47
US$69,316 		20,000 +6.8% 3.47 US$69,316
2019-07-15 2019-07-11 B Purchase
2.2
Sank Leonard
1,320 +0.4%
3.22
US$4,250 		1,320 +0.4% 3.22 US$4,250
2018-08-13 2018-08-09 B Purchase Friedman Aviad Non-Executive Director
2,000 +19.6%
4.98
US$9,960 		2,000 +19.6% 4.98 US$9,960
2018-08-13 2018-08-09 B Purchase Friedman Aviad Non-Executive Director
500 +5.2%
4.82
US$2,410 		500 +5.2% 4.82 US$2,410
2018-07-12 2018-07-11 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
122 +0.0%
5.92
US$722 		122 +0.0% 5.92 US$722
2018-07-12 2018-07-10 S Sale KIDRON NADAV

President and CEO

Executive Director Large shareholder
61 -0.0%
5.98
US$365 		61 -0.0% 5.98 US$365
2017-08-03 2017-08-02 S Sale Kidron Miriam

Chief Scientific Officer

Executive Director
89,636 -54.4%
8.50
US$761,906 		89,636 -54.4% 8.50 US$761,906
2017-08-03 2017-08-02 B Purchase Li Xiaopeng
89,636 +76.8%
8.50
US$761,906 		89,636 +76.8% 8.50 US$761,906
2017-04-19 2017-04-19 B Purchase Li Xiaopeng
52,814 +82.7%
6.33
US$334,313 		52,814 +82.7% 6.33 US$334,313
2017-04-19 2017-04-19 S Sale Kidron Miriam

Chief Scientific Officer

Executive Director
52,814 -37.1%
6.33
US$334,313 		52,814 -37.1% 6.33 US$334,313
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
7.10
US$710 		100 +0.0% 7.10 US$710
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
300 +0.0%
7.00
US$2,100 		300 +0.0% 7.00 US$2,100
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
300 +0.0%
6.91
US$2,073 		300 +0.0% 6.91 US$2,073
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
300 +0.0%
6.90
US$2,070 		300 +0.0% 6.90 US$2,070
2016-03-14 2016-03-10 S Sale JACOB HAROLD Non-Executive Director
8,500 -34.1%
6.45
US$54,842 		8,500 -34.1% 6.45 US$54,842
2015-12-31 2015-12-30 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
24,000 -14.4%
8.61
US$206,707 		24,000 -14.4% 8.61 US$206,707
2015-12-31 2015-12-29 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
15,000 -8.3%
9.08
US$136,178 		15,000 -8.3% 9.08 US$136,178
2015-12-31 2015-12-28 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
11,000 -5.7%
9.27
US$101,915 		11,000 -5.7% 9.27 US$101,915
2015-12-10 2015-12-09 S Sale Berelowitz Michael Non-Executive Director
700 -3.0%
9.44
US$6,608 		700 -3.0% 9.44 US$6,608
2015-12-09 2015-12-08 S Sale Berelowitz Michael Non-Executive Director
761 -3.1%
8.70
US$6,621 		761 -3.1% 8.70 US$6,621
2015-12-09 2015-12-07 S Sale Berelowitz Michael Non-Executive Director
539 -2.2%
8.70
US$4,689 		539 -2.2% 8.70 US$4,689
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
6.64
US$664 		100 +0.0% 6.64 US$664
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
200 +0.0%
6.63
US$1,326 		200 +0.0% 6.63 US$1,326
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
6.62
US$662 		100 +0.0% 6.62 US$662
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
200 +0.0%
6.55
US$1,310 		200 +0.0% 6.55 US$1,310
2015-03-20 2015-03-19 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
4.00
US$400 		100 +0.0% 4.00 US$400
2015-03-20 2015-03-19 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
1,100 +0.1%
3.92
US$4,312 		1,100 +0.1% 3.92 US$4,312
2015-03-20 2015-03-19 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
400 +0.0%
3.95
US$1,580 		400 +0.0% 3.95 US$1,580
2015-03-20 2015-03-18 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
500 +0.1%
3.80
US$1,900 		500 +0.1% 3.80 US$1,900
2015-03-20 2015-03-18 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
500 +0.1%
3.78
US$1,890 		500 +0.1% 3.78 US$1,890
2014-09-12 2014-09-11 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
8,699 -7.8%
8.44
US$73,401 		8,699 -7.8% 8.44 US$73,401
2014-09-12 2014-09-10 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
23,000 -17.1%
8.40
US$193,260 		23,000 -17.1% 8.40 US$193,260
2014-09-08 2014-09-04 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
8,301 -5.8%
9.41
US$78,112 		8,301 -5.8% 9.41 US$78,112
2014-06-10 2014-06-06 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
2,252 +0.2%
4.44
US$9,999 		2,252 +0.2% 4.44 US$9,999
2014-04-18 2014-04-14 B Purchase JACOB HAROLD Non-Executive Director
700 +inf%
14.41
US$10,087 		700 +inf% 14.41 US$10,087
2014-04-03 2014-04-01 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
137,300 -100.0%
12.03
US$1,651,582 		137,300 -100.0% 12.03 US$1,651,582
2014-04-02 2014-03-31 S Sale Berelowitz Michael Non-Executive Director
9,434 -100.0%
10.50
US$99,057 		9,434 -100.0% 10.50 US$99,057
2014-03-25 2014-03-25 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
47,300 +3.4%
10.90
US$515,551 		47,300 +3.4% 10.90 US$515,551
2014-03-25 2014-03-24 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
27,700 +2.0%
10.15
US$281,257 		27,700 +2.0% 10.15 US$281,257
2014-02-06 2014-02-06 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
26,800 +2.0%
14.96
US$400,941 		26,800 +2.0% 14.96 US$400,941
2014-02-06 2014-02-05 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
24,492 +1.8%
16.32
US$399,798 		24,492 +1.8% 16.32 US$399,798
2014-01-29 2013-12-30 S Sale JACOB HAROLD Non-Executive Director
834 -100.0%
15.00
US$12,510 		834 -100.0% 15.00 US$12,510
2013-07-12 2013-07-10 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
6,630 +0.5%
7.40
US$49,034 		6,630 +0.5% 7.40 US$49,034
2011-10-06 2011-10-04 B Purchase Sank Leonard Non-Executive Director
937,500 +inf%
0.32
US$300,000 		937,500 +inf% 0.32 US$300,000
2011-09-28 2011-09-27 S Sale Bronfeld Zeev Large shareholder
350,000 -5.7%
0.28
US$98,000 		350,000 -5.7% 0.28 US$98,000
2011-04-04 2011-03-31 B Purchase Bronfeld Zeev Large shareholder
781,250 +12.1%
0.32
US$250,000 		781,250 +12.1% 0.32 US$250,000
2008-01-17 2008-01-16 B Purchase Sank Leonard Non-Executive Director
5,000 +0.1%
0.25
US$1,250 		5,000 +0.1% 0.25 US$1,250
2008-01-17 2008-01-15 B Purchase Sank Leonard Non-Executive Director
15,650 +0.4%
0.25
US$3,912 		15,650 +0.4% 0.25 US$3,912
2008-01-09 2008-01-07 B Purchase Sank Leonard Non-Executive Director
22,840 +0.6%
0.30
US$6,852 		22,840 +0.6% 0.30 US$6,852
2008-01-07 2008-01-03 B Purchase Sank Leonard Non-Executive Director
48,000 +1.4%
0.30
US$14,400 		48,000 +1.4% 0.30 US$14,400
2008-01-03 2008-01-02 B Purchase Sank Leonard Non-Executive Director
121,160 +3.6%
0.30
US$35,948 		121,160 +3.6% 0.30 US$35,948
2008-01-03 2007-12-31 B Purchase Sank Leonard Non-Executive Director
85,000 +2.6%
0.24
US$20,247 		85,000 +2.6% 0.24 US$20,247
2008-01-03 2007-12-31 B Purchase Sank Leonard Non-Executive Director
10,000 +0.3%
0.25
US$2,500 		10,000 +0.3% 0.25 US$2,500
2004-06-10 2004-05-27 S Sale Young Michael

Fmr.Pres,CEO,Director,10%Owner
6,000,000 -100.0%
0.00
US$19,800 		6,000,000 -100.0% 0.00 US$19,800
Explore more

More insider trading research around Oramed Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America